RNAi Drug Delivery Market by Drug Delivery (nanoparticle drug delivery technology, pulmonary drug delivery technology, nucleic acid drug delivery technology and aptamer drug delivery technology), by Therapeutic Application (infectious diseases, cardiology, oncology, neurology, ophthalmology and metabolic disorders), and by Region –Global Industry Analysis, Share, Size, Growth, Trends, and Forecasts (2016-2021)

RNAi Drug Delivery Market by Drug Delivery (nanoparticle drug delivery technology, pulmonary drug delivery technology, nucleic acid drug delivery technology and aptamer drug delivery technology), by Therapeutic Application (infectious diseases, cardiology, oncology, neurology, ophthalmology and metabolic disorders), and by Region –Global Industry Analysis, Share, Size, Growth, Trends, and Forecasts (2016-2021)

ID: 1976 | Pages: 175 | May 2017 | Region: Global


Global RNAi Drug Delivery Market was worth USD 24.35 billion in 2016 and is expected to reach USD 81.07 billion by 2021 with a CAGR of 27.2 %. RNAi is a defense mechanism employed by Eukaryotes to degrade exogenous genes such as viruses. It is exclusively called gene silencing. We can initiate this by injecting RNAi-based drugs into the human body which is called RNAi Drug Delivery.

RNAi Drug Delivery is an emerging therapeutic method. This method is specific to the point and has fewer side effects. It is possible to cure cancer with this method by controlling gene mutation. From 2006 onwards various clinical trials are being held and people are investing billions in this market to approve and research various types of RNAi-based Drugs.

Some factors like Increasing prevalence of chronic diseases like cancer and heart diseases and innovative Applications of drug delivery market are driving this market. In addition, Research carried out in RNA Therapeutic field has also amplified the growth in Global RNA Drug Delivery Market. But, High investment and strict regulations are some of the major restraints to this market. Delivery of RNAi Drugs to specific tissues is the key challenge faced by the market.

Global RNAi Drug Delivery market is segmented based on Drug Delivery and Therapeutic Application. Based on Drug Delivery, this market is further segmented into nanoparticle drug delivery technology, nucleic acid drug delivery technology, aptamer drug delivery technology, and pulmonary drug delivery technology. Based on Therapeutic Application, the market is further segmented into infectious diseases, cardiology, oncology, neurology, ophthalmology and metabolic disorders. nanoparticle Drug Delivery is largest sub-segment in this market because of its use in selected delivery of drugs. However, aptamer drug delivery technology is the fastest growing segment.

Based on Geography, this market is further segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America has the largest share in the market followed by Europe because of their high investments. However, Asia-Pacific market is expected to increase at highest CAGR in the following five years because of increasing investments by the major players in this region

Key players in this region are Alnylam Pharmaceuticals Inc., Merck & Co. Inc, Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals Inc, Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Traversa Therapeutics Inc., Tacere Therapeutics Inc., Sirnaomics Inc., and PhaseRx Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug delivery                             

                                5.1.1 Introduction           

                                5.1.2 nanoparticle drug delivery technology        

                                5.1.3 pulmonary drug delivery technology           

                                5.1.4 nucleic acid drug delivery technology          

                                5.1.5  aptamer drug delivery technology               

                                5.1.6  Y-o-Y Growth Analysis, By Drug Delivery   

                                5.1.7  Market Attractiveness Analysis, By Drug delivery 

                                5.1.8 Market Share Analysis, By drug Delivery    

                5.2 Therapeutic Application                        

                                5.2.1 Introduction           

                                5.2.2 infectious diseases              

                                5.2.3 cardiology

                                5.2.4 oncology  

                                5.2.5 neurology

                                5.2.6 ophthalmology      

                                5.2.7 metabolic disorders            

                                5.2.8  Y-o-Y Growth Analysis, By Therapeutic Application              

                                5.2.9  Market Attractiveness Analysis, By Therapeutic Application            

                                5.2.10 Market Share Analysis, By Therapeutic Application             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Delivery

                                                6.1.3.3 By Therapeutic Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Delivery

                                                6.1.4.3 By Therapeutic Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Delivery

                                                6.1.5.3 By Therapeutic Application

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Alnylam Pharmaceuticals Inc.                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co. Inc                        

                8.3 Access Pharmaceuticals Inc.                

                8.4 Dicerna Pharmaceuticals Inc.                              

                8.5 Tekmira Pharmaceuticals Corp.                          

                8.6 Isis Pharmaceuticals Inc                         

                8.7 Calondo Pharmaceuticals Inc.                             

                8.8 Marina Biotech Inc.                 

                8.9 RXi Pharmaceuticals Corp                     

                8.10 Quark Pharmaceuticals Inc                

                8.11 Silence Therapeutics plc                     

                8.12 Traversa Therapeutics Inc.                 

                8.13 Tacere Therapeutics Inc                      

                8.14 Sirnaomics Inc.                        

                8.15 PhaseRx Inc.                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global RNAi Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  2. Global RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  3. Global nanoparticle drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  4. Global pulmonary drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  5. Global nucleic acid drug delivery technology  Market By Region, From 2016-2021 ( USD Million )
  6. Global aptamer drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  7. Global RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  8. Global infectious diseases Market By Region, From 2016-2021 ( USD Million )
  9. Global cardiology Market By Region, From 2016-2021 ( USD Million )
  10. Global oncology Market By Region, From 2016-2021 ( USD Million )
  11. Global neurology Market By Region, From 2016-2021 ( USD Million )
  12. Global ophthalmology Market By Region, From 2016-2021 ( USD Million )
  13. Global metabolic disorders Market By Region, From 2016-2021 ( USD Million )
  14. North America RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  15. North America nanoparticle drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  16. North America pulmonary drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  17. North America nucleic acid drug delivery technology  Market By Region, From 2016-2021 ( USD Million )
  18. North America aptamer drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  19. North America RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  20. North America infectious diseases Market By Region, From 2016-2021 ( USD Million )
  21. North America cardiology Market By Region, From 2016-2021 ( USD Million )
  22. North America oncology Market By Region, From 2016-2021 ( USD Million )
  23. North America neurology Market By Region, From 2016-2021 ( USD Million )
  24. North America ophthalmology Market By Region, From 2016-2021 ( USD Million )
  25. North America metabolic disorders Market By Region, From 2016-2021 ( USD Million )
  26. United States RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  27. United States RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  28. Canada RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  29. Canada RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  30. Europe RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  31. Europe nanoparticle drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  32. Europe pulmonary drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  33. Europe nucleic acid drug delivery technology  Market By Region, From 2016-2021 ( USD Million )
  34. Europe aptamer drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  35. Europe RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  36. Europe infectious diseases Market By Region, From 2016-2021 ( USD Million )
  37. Europe cardiology Market By Region, From 2016-2021 ( USD Million )
  38. Europe oncology Market By Region, From 2016-2021 ( USD Million )
  39. Europe neurology Market By Region, From 2016-2021 ( USD Million )
  40. Europe ophthalmology Market By Region, From 2016-2021 ( USD Million )
  41. Europe metabolic disorders Market By Region, From 2016-2021 ( USD Million )
  42. U.K. RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  43. U.K. RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  44. Germany RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  45. Germany RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  46. France RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  47. France RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  48. Italy RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  49. Italy RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  50. Spain RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  51. Spain RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  52. Asia-Pacific RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  53. Asia-Pacific nanoparticle drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  54. Asia-Pacific pulmonary drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  55. Asia-Pacific nucleic acid drug delivery technology  Market By Region, From 2016-2021 ( USD Million )
  56. Asia-Pacific aptamer drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  57. Asia-Pacific RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  58. Asia-Pacific infectious diseases Market By Region, From 2016-2021 ( USD Million )
  59. Asia-Pacific cardiology Market By Region, From 2016-2021 ( USD Million )
  60. Asia-Pacific oncology Market By Region, From 2016-2021 ( USD Million )
  61. Asia-Pacific neurology Market By Region, From 2016-2021 ( USD Million )
  62. Asia-Pacific ophthalmology Market By Region, From 2016-2021 ( USD Million )
  63. Asia-Pacific metabolic disorders Market By Region, From 2016-2021 ( USD Million )
  64. Japan RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  65. Japan RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  66. China RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  67. China RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  68. India RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  69. India RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  70. Australia RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  71. Australia RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  72. South Korea RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  73. South Korea RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  74. Latin America RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  75. Latin America nanoparticle drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  76. Latin America pulmonary drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  77. Latin America nucleic acid drug delivery technology  Market By Region, From 2016-2021 ( USD Million )
  78. Latin America aptamer drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  79. Latin America RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  80. Latin America infectious diseases Market By Region, From 2016-2021 ( USD Million )
  81. Latin America cardiology Market By Region, From 2016-2021 ( USD Million )
  82. Latin America oncology Market By Region, From 2016-2021 ( USD Million )
  83. Latin America neurology Market By Region, From 2016-2021 ( USD Million )
  84. Latin America ophthalmology Market By Region, From 2016-2021 ( USD Million )
  85. Latin America metabolic disorders Market By Region, From 2016-2021 ( USD Million )
  86. Brazil RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  87. Brazil RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  88. Argentina RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  89. Argentina RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  90. Mexico RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  91. Mexico RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  92. Rest of Latin America RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  93. Rest of Latin America RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  94. Middle East & Africa RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  95. Middle East & Africa nanoparticle drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  96. Middle East & Africa pulmonary drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  97. Middle East & Africa nucleic acid drug delivery technology  Market By Region, From 2016-2021 ( USD Million )
  98. Middle East & Africa aptamer drug delivery technology Market By Region, From 2016-2021 ( USD Million )
  99. Middle East & Africa RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  100. Middle East & Africa infectious diseases Market By Region, From 2016-2021 ( USD Million )
  101. Middle East & Africa cardiology Market By Region, From 2016-2021 ( USD Million )
  102. Middle East & Africa oncology Market By Region, From 2016-2021 ( USD Million )
  103. Middle East & Africa neurology Market By Region, From 2016-2021 ( USD Million )
  104. Middle East & Africa ophthalmology Market By Region, From 2016-2021 ( USD Million )
  105. Middle East & Africa metabolic disorders Market By Region, From 2016-2021 ( USD Million )
  106. Middle East RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  107. Middle East RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
  108. Africa RNAi Drug Delivery Market By Drug Delivery, From 2016-2021 ( USD Million )
  109. Africa RNAi Drug Delivery Market By Therapeutic Applications, From 2016-2021 ( USD Million )
Middle East And Africa Dental Lasers Market By Product (Soft Tissue, All Tissue, Dental Welding Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), By End User (Hospitals, Clinics)...
Latin America Dental Lasers Market By Product (Soft Tissue, All Tissue, Dental Welding Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), By End User (Hospitals, Clinics) And By R...
Middle East And Africa Soft Tissue Repair Market By Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) By Application (Hernia, Dural, Orthopedic, Skin, De...
Latin America Soft Tissue Repair Market By Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) By Application (Hernia, Dural, Orthopedic, Skin, Dental, Vag...
Asia Pacific Soft Tissue Repair Market By Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) By Application (Hernia, Dural, Orthopedic, Skin, Dental, Vagi...
Europe Soft Tissue Repair Market By Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) By Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, B...
North America Soft Tissue Repair Market By Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) By Application (Hernia, Dural, Orthopedic, Skin, Dental, Vag...
Soft Tissue Repair Market By Product (Mesh/Tissue Patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) By Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast A...
Asia Pacific Dental Lasers Market By Product (Soft Tissue, All Tissue, Dental Welding Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), By End User (Hospitals, Clinics) And By Re...
North America Dental Lasers Market By Product (Soft Tissue, All Tissue, Dental Welding Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), By End User (Hospitals, Clinics) And By R...
Europe Dental Lasers Market By Product (Soft Tissue, All Tissue, Dental Welding Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), By End User (Hospitals, Clinics) And By Region ...
Dental Lasers Market By Product (Soft Tissue, All Tissue, Dental Welding Lasers), By Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), By End User (Hospitals, Clinics) And By Region - Globa...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.